Inflammation markers as mediators of vasculo-endothelial dysfunction and atherosclerosis in the metabolic syndrome

Chin Med J (Engl). 2007 Nov 5;120(21):1918-24.

Author

Affiliation

¹ Diabetes Unit, Division of Endocrinology, University of South Carolina School of Medicine, Columbia, SC 29203, USA. arizvi@gw.mp.sc.edu

PMID: 18067768

No abstract available

Publication types

Review

MeSH terms

Atherosclerosis / immunology
Atherosclerosis / metabolism*
Atherosclerosis / pathology
Biomarkers / metabolism
C-Reactive Protein / metabolism
Endothelium, Vascular / metabolism*
Endothelium, Vascular / pathology
Endothelium, Vascular / physiopathology
Inflammation / metabolism*
Inflammation / pathology
Inflammation Mediators / metabolism*
Interleukins / metabolism
Metabolic Syndrome / metabolism*
Metabolic Syndrome / pathology
Tumor Necrosis Factor-alpha / metabolism

Substances

Biomarkers
Inflammation Mediators
Interleukins
Tumor Necrosis Factor-alpha
C-Reactive Protein